Industry Research Reports

Home > Reports > Medical Care > Vertebroplasty & Kyphoplasty - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Vertebroplasty & Kyphoplasty - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Care

Published Date: 2026-07-14

Pages: 120 Pages

Report ld: 6940299

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Vertebroplasty & Kyphoplasty Market Size(US$)

CAGR 2026-2032

3.4%

Market Size,2032

USD 1,722

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 1,406 million

Market Forecast in 2032(Value)

US$ 1,722 million

CAGR

3.4%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Vertebroplasty & Kyphoplasty was estimated to be worth US$ 1363 million in 2025 and is projected to reach US$ 1722 million, growing at a CAGR of 3.4% from 2026 to 2032.

Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.

Global Vertebroplasty and Kyphoplasty Devices key players include Medtronic, Stryker, J&J (Depuy Synthes), Globus Medical, Merit Medical, etc. Global top five manufacturers hold a share about 85%. North America is the largest market, with a share about 55%, followed by Asia-Pacific, with a share about 25 percent. In terms of product, Kyphoplasty is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Ambulatory Surgery Center, etc.

This report provides a comprehensive view of the global market for Vertebroplasty & Kyphoplasty, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Vertebroplasty & Kyphoplasty market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Vertebroplasty & Kyphoplasty.

Market Segmentation

By Company

Depuy Synthes
Stryker Corporation
CareFusion Corporation
Osseon LLC.
Alphatec Spine, Inc.
TAEYEON MEDICAL Co., Ltd.
G-21 S.R.L
BMK Global Medical Company
Medtronic, Inc.,
Globus Medical, Inc
SOMATEX

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Vertebroplastic Device
Kyphoplastic Device

Segment by Application

Hospitals
Clinics
Others

biaoTi Chapter Outline

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Vertebroplasty & Kyphoplasty companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Vertebroplasty & Kyphoplasty revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Vertebroplasty & Kyphoplasty revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi Why This Report?

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

Table of Contents

1 Market Overview

1.1 Vertebroplasty & Kyphoplasty Product Introduction

1.2 Global Vertebroplasty & Kyphoplasty Market Size Forecast (2021–2032)

1.3 Vertebroplasty & Kyphoplasty Market Trends & Drivers

1.3.1 Vertebroplasty & Kyphoplasty Industry Trends

1.3.2 Vertebroplasty & Kyphoplasty Market Drivers & Opportunities

1.3.3 Vertebroplasty & Kyphoplasty Market Challenges

1.3.4 Vertebroplasty & Kyphoplasty Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Vertebroplasty & Kyphoplasty Players Revenue Ranking (2025)

2.2 Global Vertebroplasty & Kyphoplasty Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Vertebroplasty & Kyphoplasty Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Vertebroplasty & Kyphoplasty

2.6 Vertebroplasty & Kyphoplasty Market Competitive Analysis

2.6.1 Vertebroplasty & Kyphoplasty Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Vertebroplasty & Kyphoplasty Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Vertebroplasty & Kyphoplasty revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Vertebroplasty & Kyphoplasty Market Classification

3.1 Introduction by Type

3.1.1 Vertebroplastic Device

3.1.2 Kyphoplastic Device

3.1.3 Global Vertebroplasty & Kyphoplasty Sales Value by Type

3.1.3.1 Global Vertebroplasty & Kyphoplasty Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Vertebroplasty & Kyphoplasty Sales Value, by Type (2021–2032)

3.1.3.3 Global Vertebroplasty & Kyphoplasty Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Clinics

4.1.3 Others

4.2 Global Vertebroplasty & Kyphoplasty Sales Value by Application

4.2.1 Global Vertebroplasty & Kyphoplasty Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Vertebroplasty & Kyphoplasty Sales Value by Application (2021–2032)

4.2.3 Global Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Vertebroplasty & Kyphoplasty Sales Value by Region

5.1.1 Global Vertebroplasty & Kyphoplasty Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Vertebroplasty & Kyphoplasty Sales Value by Region (2021–2026)

5.1.3 Global Vertebroplasty & Kyphoplasty Sales Value by Region (2027–2032)

5.1.4 Global Vertebroplasty & Kyphoplasty Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Vertebroplasty & Kyphoplasty Sales Value, 2021–2032

5.2.2 North America Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Vertebroplasty & Kyphoplasty Sales Value, 2021–2032

5.3.2 Europe Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Vertebroplasty & Kyphoplasty Sales Value, 2021–2032

5.4.2 Asia Pacific Vertebroplasty & Kyphoplasty Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Vertebroplasty & Kyphoplasty Sales Value, 2021–2032

5.5.2 South America Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Vertebroplasty & Kyphoplasty Sales Value, 2021–2032

5.6.2 Middle East & Africa Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Vertebroplasty & Kyphoplasty Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Vertebroplasty & Kyphoplasty Sales Value, 2021–2032

6.3 United States

6.3.1 United States Vertebroplasty & Kyphoplasty Sales Value, 2021–2032

6.3.2 United States Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Vertebroplasty & Kyphoplasty Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Vertebroplasty & Kyphoplasty Sales Value, 2021–2032

6.4.2 Europe Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Vertebroplasty & Kyphoplasty Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Vertebroplasty & Kyphoplasty Sales Value, 2021–2032

6.5.2 China Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2025 vs 2032

6.5.3 China Vertebroplasty & Kyphoplasty Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Vertebroplasty & Kyphoplasty Sales Value, 2021–2032

6.6.2 Japan Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Vertebroplasty & Kyphoplasty Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Vertebroplasty & Kyphoplasty Sales Value, 2021–2032

6.7.2 South Korea Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Vertebroplasty & Kyphoplasty Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Vertebroplasty & Kyphoplasty Sales Value, 2021–2032

6.8.2 Southeast Asia Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Vertebroplasty & Kyphoplasty Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Vertebroplasty & Kyphoplasty Sales Value, 2021–2032

6.9.2 India Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2025 vs 2032

6.9.3 India Vertebroplasty & Kyphoplasty Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Depuy Synthes

7.1.1 Depuy Synthes Profile

7.1.2 Depuy Synthes Main Business

7.1.3 Depuy Synthes Vertebroplasty & Kyphoplasty Products, Services, and Solutions

7.1.4 Depuy Synthes Vertebroplasty & Kyphoplasty Revenue (US$ Million), 2021–2026

7.1.5 Depuy Synthes Recent Developments

7.2 Stryker Corporation

7.2.1 Stryker Corporation Profile

7.2.2 Stryker Corporation Main Business

7.2.3 Stryker Corporation Vertebroplasty & Kyphoplasty Products, Services, and Solutions

7.2.4 Stryker Corporation Vertebroplasty & Kyphoplasty Revenue (US$ Million), 2021–2026

7.2.5 Stryker Corporation Recent Developments

7.3 CareFusion Corporation

7.3.1 CareFusion Corporation Profile

7.3.2 CareFusion Corporation Main Business

7.3.3 CareFusion Corporation Vertebroplasty & Kyphoplasty Products, Services, and Solutions

7.3.4 CareFusion Corporation Vertebroplasty & Kyphoplasty Revenue (US$ Million), 2021–2026

7.3.5 CareFusion Corporation Recent Developments

7.4 Osseon LLC.

7.4.1 Osseon LLC. Profile

7.4.2 Osseon LLC. Main Business

7.4.3 Osseon LLC. Vertebroplasty & Kyphoplasty Products, Services, and Solutions

7.4.4 Osseon LLC. Vertebroplasty & Kyphoplasty Revenue (US$ Million), 2021–2026

7.4.5 Osseon LLC. Recent Developments

7.5 Alphatec Spine, Inc.

7.5.1 Alphatec Spine, Inc. Profile

7.5.2 Alphatec Spine, Inc. Main Business

7.5.3 Alphatec Spine, Inc. Vertebroplasty & Kyphoplasty Products, Services, and Solutions

7.5.4 Alphatec Spine, Inc. Vertebroplasty & Kyphoplasty Revenue (US$ Million), 2021–2026

7.5.5 Alphatec Spine, Inc. Recent Developments

7.6 TAEYEON MEDICAL Co., Ltd.

7.6.1 TAEYEON MEDICAL Co., Ltd. Profile

7.6.2 TAEYEON MEDICAL Co., Ltd. Main Business

7.6.3 TAEYEON MEDICAL Co., Ltd. Vertebroplasty & Kyphoplasty Products, Services, and Solutions

7.6.4 TAEYEON MEDICAL Co., Ltd. Vertebroplasty & Kyphoplasty Revenue (US$ Million), 2021–2026

7.6.5 TAEYEON MEDICAL Co., Ltd. Recent Developments

7.7 G-21 S.R.L

7.7.1 G-21 S.R.L Profile

7.7.2 G-21 S.R.L Main Business

7.7.3 G-21 S.R.L Vertebroplasty & Kyphoplasty Products, Services, and Solutions

7.7.4 G-21 S.R.L Vertebroplasty & Kyphoplasty Revenue (US$ Million), 2021–2026

7.7.5 G-21 S.R.L Recent Developments

7.8 BMK Global Medical Company

7.8.1 BMK Global Medical Company Profile

7.8.2 BMK Global Medical Company Main Business

7.8.3 BMK Global Medical Company Vertebroplasty & Kyphoplasty Products, Services, and Solutions

7.8.4 BMK Global Medical Company Vertebroplasty & Kyphoplasty Revenue (US$ Million), 2021–2026

7.8.5 BMK Global Medical Company Recent Developments

7.9 Medtronic, Inc.,

7.9.1 Medtronic, Inc., Profile

7.9.2 Medtronic, Inc., Main Business

7.9.3 Medtronic, Inc., Vertebroplasty & Kyphoplasty Products, Services, and Solutions

7.9.4 Medtronic, Inc., Vertebroplasty & Kyphoplasty Revenue (US$ Million), 2021–2026

7.9.5 Medtronic, Inc., Recent Developments

7.10 Globus Medical, Inc

7.10.1 Globus Medical, Inc Profile

7.10.2 Globus Medical, Inc Main Business

7.10.3 Globus Medical, Inc Vertebroplasty & Kyphoplasty Products, Services, and Solutions

7.10.4 Globus Medical, Inc Vertebroplasty & Kyphoplasty Revenue (US$ Million), 2021–2026

7.10.5 Globus Medical, Inc Recent Developments

7.11 SOMATEX

7.11.1 SOMATEX Profile

7.11.2 SOMATEX Main Business

7.11.3 SOMATEX Vertebroplasty & Kyphoplasty Products, Services, and Solutions

7.11.4 SOMATEX Vertebroplasty & Kyphoplasty Revenue (US$ Million), 2021–2026

7.11.5 SOMATEX Recent Developments

8 Industry Chain Analysis

8.1 Vertebroplasty & Kyphoplasty Value Chain

8.2 Vertebroplasty & Kyphoplasty Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Vertebroplasty & Kyphoplasty Sales Model

8.5.2 Sales Channels

8.5.3 Vertebroplasty & Kyphoplasty Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

Table of Figures

List of Tables

Table 1. Vertebroplasty & Kyphoplasty Market Trends

Table 2. Vertebroplasty & Kyphoplasty Market Drivers & Opportunities

Table 3. Vertebroplasty & Kyphoplasty Market Challenges

Table 4. Vertebroplasty & Kyphoplasty Market Restraints

Table 5. Global Vertebroplasty & Kyphoplasty Revenue by Company (US$ Million), 2021–2026

Table 6. Global Vertebroplasty & Kyphoplasty Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Vertebroplasty & Kyphoplasty Product Type

Table 9. Key Companies General Availability (GA) Timeline for Vertebroplasty & Kyphoplasty

Table 10. Global Vertebroplasty & Kyphoplasty Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Vertebroplasty & Kyphoplasty revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Vertebroplasty & Kyphoplasty Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Vertebroplasty & Kyphoplasty Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Vertebroplasty & Kyphoplasty Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Vertebroplasty & Kyphoplasty Sales Market Share in Value by Type (2021–2026)

Table 17. Global Vertebroplasty & Kyphoplasty Sales Market Share in Value by Type (2027–2032)

Table 18. Global Vertebroplasty & Kyphoplasty Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Vertebroplasty & Kyphoplasty Sales Value by Application (US$ Million), 2021–2026

Table 20. Global Vertebroplasty & Kyphoplasty Sales Value by Application (US$ Million), 2027–2032

Table 21. Global Vertebroplasty & Kyphoplasty Sales Market Share in Value by Application (2021–2026)

Table 22. Global Vertebroplasty & Kyphoplasty Sales Market Share in Value by Application (2027–2032)

Table 23. Global Vertebroplasty & Kyphoplasty Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global Vertebroplasty & Kyphoplasty Sales Value by Region (US$ Million), 2021–2026

Table 25. Global Vertebroplasty & Kyphoplasty Sales Value by Region (US$ Million), 2027–2032

Table 26. Global Vertebroplasty & Kyphoplasty Sales Value by Region (%), 2021–2026

Table 27. Global Vertebroplasty & Kyphoplasty Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions Vertebroplasty & Kyphoplasty Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions Vertebroplasty & Kyphoplasty Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions Vertebroplasty & Kyphoplasty Sales Value, (US$ Million), 2027–2032

Table 31. Depuy Synthes Basic Information List

Table 32. Depuy Synthes Description and Business Overview

Table 33. Depuy Synthes Vertebroplasty & Kyphoplasty Products, Services, and Solutions

Table 34. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of Depuy Synthes (2021–2026)

Table 35. Depuy Synthes Recent Developments

Table 36. Stryker Corporation Basic Information List

Table 37. Stryker Corporation Description and Business Overview

Table 38. Stryker Corporation Vertebroplasty & Kyphoplasty Products, Services, and Solutions

Table 39. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of Stryker Corporation (2021–2026)

Table 40. Stryker Corporation Recent Developments

Table 41. CareFusion Corporation Basic Information List

Table 42. CareFusion Corporation Description and Business Overview

Table 43. CareFusion Corporation Vertebroplasty & Kyphoplasty Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of CareFusion Corporation (2021–2026)

Table 45. CareFusion Corporation Recent Developments

Table 46. Osseon LLC. Basic Information List

Table 47. Osseon LLC. Description and Business Overview

Table 48. Osseon LLC. Vertebroplasty & Kyphoplasty Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of Osseon LLC. (2021–2026)

Table 50. Osseon LLC. Recent Developments

Table 51. Alphatec Spine, Inc. Basic Information List

Table 52. Alphatec Spine, Inc. Description and Business Overview

Table 53. Alphatec Spine, Inc. Vertebroplasty & Kyphoplasty Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of Alphatec Spine, Inc. (2021–2026)

Table 55. Alphatec Spine, Inc. Recent Developments

Table 56. TAEYEON MEDICAL Co., Ltd. Basic Information List

Table 57. TAEYEON MEDICAL Co., Ltd. Description and Business Overview

Table 58. TAEYEON MEDICAL Co., Ltd. Vertebroplasty & Kyphoplasty Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of TAEYEON MEDICAL Co., Ltd. (2021–2026)

Table 60. TAEYEON MEDICAL Co., Ltd. Recent Developments

Table 61. G-21 S.R.L Basic Information List

Table 62. G-21 S.R.L Description and Business Overview

Table 63. G-21 S.R.L Vertebroplasty & Kyphoplasty Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of G-21 S.R.L (2021–2026)

Table 65. G-21 S.R.L Recent Developments

Table 66. BMK Global Medical Company Basic Information List

Table 67. BMK Global Medical Company Description and Business Overview

Table 68. BMK Global Medical Company Vertebroplasty & Kyphoplasty Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of BMK Global Medical Company (2021–2026)

Table 70. BMK Global Medical Company Recent Developments

Table 71. Medtronic, Inc., Basic Information List

Table 72. Medtronic, Inc., Description and Business Overview

Table 73. Medtronic, Inc., Vertebroplasty & Kyphoplasty Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of Medtronic, Inc., (2021–2026)

Table 75. Medtronic, Inc., Recent Developments

Table 76. Globus Medical, Inc Basic Information List

Table 77. Globus Medical, Inc Description and Business Overview

Table 78. Globus Medical, Inc Vertebroplasty & Kyphoplasty Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of Globus Medical, Inc (2021–2026)

Table 80. Globus Medical, Inc Recent Developments

Table 81. SOMATEX Basic Information List

Table 82. SOMATEX Description and Business Overview

Table 83. SOMATEX Vertebroplasty & Kyphoplasty Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of SOMATEX (2021–2026)

Table 85. SOMATEX Recent Developments

Table 86. Revenue (US$ Million) in Vertebroplasty & Kyphoplasty Business of Company 40 (2021–2026)

Table 87. Company 40 Recent Developments

Table 88. Key Raw Materials Lists

Table 89. Key Suppliers of Raw Materials Lists

Table 90. Vertebroplasty & Kyphoplasty Downstream Customers

Table 91. Vertebroplasty & Kyphoplasty Distributors List

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

List of Figures

Figure 1. Vertebroplasty & Kyphoplasty Product Picture

Figure 2. Global Vertebroplasty & Kyphoplasty Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Vertebroplasty & Kyphoplasty Sales Value (US$ Million), 2021–2032

Figure 4. Vertebroplasty & Kyphoplasty Report Years Considered

Figure 5. Global Vertebroplasty & Kyphoplasty Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Vertebroplasty & Kyphoplasty Revenue in 2025

Figure 7. Vertebroplasty & Kyphoplasty Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Vertebroplastic Device Picture

Figure 9. Kyphoplastic Device Picture

Figure 10. Global Vertebroplasty & Kyphoplasty Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Vertebroplasty & Kyphoplasty Sales Value Market Share by Type, 2025 & 2032

Figure 12. Product Picture of Hospitals

Figure 13. Product Picture of Clinics

Figure 14. Product Picture of Others

Figure 15. Global Vertebroplasty & Kyphoplasty Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Vertebroplasty & Kyphoplasty Sales Value Market Share by Application, 2025 & 2032

Figure 17. North America Vertebroplasty & Kyphoplasty Sales Value (US$ Million), 2021–2032

Figure 18. North America Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2025 vs 2032

Figure 19. Europe Vertebroplasty & Kyphoplasty Sales Value (US$ Million), 2021–2032

Figure 20. Europe Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2025 vs 2032

Figure 21. Asia Pacific Vertebroplasty & Kyphoplasty Sales Value (US$ Million), 2021–2032

Figure 22. Asia Pacific Vertebroplasty & Kyphoplasty Sales Value by Subregion (%), 2025 vs 2032

Figure 23. South America Vertebroplasty & Kyphoplasty Sales Value (US$ Million), 2021–2032

Figure 24. South America Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2025 vs 2032

Figure 25. Middle East & Africa Vertebroplasty & Kyphoplasty Sales Value (US$ Million), 2021–2032

Figure 26. Middle East & Africa Vertebroplasty & Kyphoplasty Sales Value by Country (%), 2025 vs 2032

Figure 27. Key Countries/Regions Vertebroplasty & Kyphoplasty Sales Value (%), 2021–2032

Figure 28. United States Vertebroplasty & Kyphoplasty Sales Value (US$ Million), 2021–2032

Figure 29. United States Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2025 vs 2032

Figure 30. United States Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2025 vs 2032

Figure 31. Europe Vertebroplasty & Kyphoplasty Sales Value (US$ Million), 2021–2032

Figure 32. Europe Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2025 vs 2032

Figure 33. Europe Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2025 vs 2032

Figure 34. China Vertebroplasty & Kyphoplasty Sales Value (US$ Million), 2021–2032

Figure 35. China Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2025 vs 2032

Figure 36. China Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2025 vs 2032

Figure 37. Japan Vertebroplasty & Kyphoplasty Sales Value (US$ Million), 2021–2032

Figure 38. Japan Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2025 vs 2032

Figure 39. Japan Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2025 vs 2032

Figure 40. South Korea Vertebroplasty & Kyphoplasty Sales Value (US$ Million), 2021–2032

Figure 41. South Korea Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2025 vs 2032

Figure 42. South Korea Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2025 vs 2032

Figure 43. Southeast Asia Vertebroplasty & Kyphoplasty Sales Value (US$ Million), 2021–2032

Figure 44. Southeast Asia Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2025 vs 2032

Figure 45. Southeast Asia Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2025 vs 2032

Figure 46. India Vertebroplasty & Kyphoplasty Sales Value (US$ Million), 2021–2032

Figure 47. India Vertebroplasty & Kyphoplasty Sales Value by Type (%), 2025 vs 2032

Figure 48. India Vertebroplasty & Kyphoplasty Sales Value by Application (%), 2025 vs 2032

Figure 49. Vertebroplasty & Kyphoplasty Value Chain

Figure 50. Vertebroplasty & Kyphoplasty Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

Related Reports

Global Vertebroplasty & Kyphoplasty Market Research Report 2024
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published Date: 2024-01-16
Pages: 88
USD 2900.00
(Single User License)
Vertebroplasty & Kyphoplasty - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published Date: 2024-01-24
Pages: 110
USD 3950.00
(Single User License)
Global Vertebroplasty & Kyphoplasty Market Insights, Forecast to 2030
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published Date: 2024-04-12
Pages: 108
USD 4900.00
(Single User License)
Global Vertebroplasty & Kyphoplasty Market Research Report 2025
The global market for Vertebroplasty & Kyphoplasty was valued at US$ 1323 million in the year 2024 and is projected to reach a revised size of US$ 1670 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published Date: 2025-02-27
Pages: 81
USD 2900.00
(Single User License)
Vertebroplasty & Kyphoplasty- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Vertebroplasty & Kyphoplasty was estimated to be worth US$ 1323 million in 2024 and is forecast to a readjusted size of US$ 1670 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 111
USD 3950.00
(Single User License)
Global Vertebroplasty & Kyphoplasty Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Vertebroplasty & Kyphoplasty market size was US$ 1323 million in 2024 and is forecast to a readjusted size of US$ 1670 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 94
USD 4250.00
(Single User License)
Global Vertebroplasty & Kyphoplasty Market Research Report 2026
The global Vertebroplasty & Kyphoplasty market was valued at US$ 1363 million in 2025 and is anticipated to reach US$ 1722 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 117
USD 2900.00
(Single User License)

Global Vertebroplasty & Kyphoplasty Market Research Report 2024
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published: 2024-01-16
Pages: 88
USD 2900.00 (Single User License)
Vertebroplasty & Kyphoplasty - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published: 2024-01-24
Pages: 110
USD 3950.00 (Single User License)
Global Vertebroplasty & Kyphoplasty Market Insights, Forecast to 2030
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published: 2024-04-12
Pages: 108
USD 4900.00 (Single User License)
Global Vertebroplasty & Kyphoplasty Market Research Report 2025
The global market for Vertebroplasty & Kyphoplasty was valued at US$ 1323 million in the year 2024 and is projected to reach a revised size of US$ 1670 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published: 2025-02-27
Pages: 81
USD 2900.00 (Single User License)
Vertebroplasty & Kyphoplasty- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Vertebroplasty & Kyphoplasty was estimated to be worth US$ 1323 million in 2024 and is forecast to a readjusted size of US$ 1670 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 111
USD 3950.00 (Single User License)
Global Vertebroplasty & Kyphoplasty Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Vertebroplasty & Kyphoplasty market size was US$ 1323 million in 2024 and is forecast to a readjusted size of US$ 1670 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 94
USD 4250.00 (Single User License)
Global Vertebroplasty & Kyphoplasty Market Research Report 2026
The global Vertebroplasty & Kyphoplasty market was valued at US$ 1363 million in 2025 and is anticipated to reach US$ 1722 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-04-27
Pages: 117
USD 2900.00 (Single User License)